[424B5] Orchestra BioMed Holdings, Inc. Prospectus Supplement (Debt Securities)
Bel Fuse Inc. (BELFB) � Form 144 notice
A holder intends to sell up to 1,200 common shares through Morgan Stanley Smith Barney on the NASDAQ beginning 31 Jul 2025. The proposed sale is valued at $152,484 and equals roughly 0.01 % of the 10,548,254 shares outstanding, indicating an immaterial portion of the float. The shares were acquired from the issuer as restricted stock on 15 Mar 2025. No other sales by this filer occurred during the past three months. The signer certifies that they possess no undisclosed material adverse information about the company.
This filing merely grants the right to sell under Rule 144; it is not a commitment that the transaction will occur, nor does it involve new share issuance, dilution, or changes to corporate guidance.
Bel Fuse Inc. (BELFB) � Avviso Modulo 144
Un detentore intende vendere fino a 1.200 azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ a partire dal 31 luglio 2025. La vendita proposta ha un valore di circa $152.484, corrispondente a circa lo 0,01% delle 10.548.254 azioni in circolazione, indicando una quota irrilevante del flottante. Le azioni sono state acquisite dall'emittente come azioni vincolate il 15 marzo 2025. Nessun'altra vendita da parte di questo dichiarante è avvenuta negli ultimi tre mesi. Il firmatario certifica di non possedere informazioni materiali sfavorevoli non divulgate riguardo alla società.
Questa comunicazione concede solo il diritto di vendere ai sensi della Regola 144; non rappresenta un impegno che la transazione avverrà, né comporta emissione di nuove azioni, diluizione o modifiche alle indicazioni societarie.
Bel Fuse Inc. (BELFB) � Aviso Formulario 144
Un titular pretende vender hasta 1,200 acciones comunes a través de Morgan Stanley Smith Barney en el NASDAQ a partir del 31 de julio de 2025. La venta propuesta tiene un valor de $152,484, lo que equivale aproximadamente al 0.01 % de las 10,548,254 acciones en circulación, indicando una porción insignificante del flotante. Las acciones fueron adquiridas del emisor como acciones restringidas el 15 de marzo de 2025. No se registraron otras ventas por parte de este declarante en los últimos tres meses. El firmante certifica que no posee información material adversa no divulgada sobre la compañía.
Este archivo únicamente otorga el derecho a vender bajo la Regla 144; no es un compromiso de que la transacción se realizará, ni implica emisión de nuevas acciones, dilución o cambios en la orientación corporativa.
Bel Fuse Inc. (BELFB) � Form 144 공시
보유자는 2025� 7� 31일부� Morgan Stanley Smith Barney� 통해 1,200 보통�� NASDAQ에서 매도� 예정입니�. 제안� 매도 금액은 $152,484이며, 이는 발행 주식 총수 10,548,254� � � 0.01%� 해당하여 유동 주식 � 미미� 비중임을 나타냅니�. 해당 주식은 2025� 3� 15일에 발행사로부� 제한 주식으로 취득하였습니�. � 신고인은 최근 3개월 내에 다른 매도� 하지 않았습니�. 서명자는 회사� 대� 미공� 중대� 부정적 정보가 없음� 증명합니�.
� 서류 제출은 Rule 144� 따른 매도 권리만을 부여하� 것으�, 거래가 반드� 이루어진다는 약속� 아니�, 신주 발행, 희석, 또는 회사 가이던� 변경과 관련이 없습니다.
Bel Fuse Inc. (BELFB) � Avis de formulaire 144
Un détenteur prévoit de vendre jusqu'à 1 200 actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ à partir du 31 juillet 2025. La vente proposée est évaluée à 152 484 $, ce qui représente environ 0,01 % des 10 548 254 actions en circulation, indiquant une part négligeable du flottant. Les actions ont été acquises auprès de l'émetteur en tant qu'actions restreintes le 15 mars 2025. Aucune autre vente de ce déclarant n'a eu lieu au cours des trois derniers mois. Le signataire certifie ne détenir aucune information défavorable importante non divulguée concernant la société.
Ce dépôt accorde uniquement le droit de vendre conformément à la règle 144 ; il ne constitue pas un engagement que la transaction aura lieu, ni n'implique d'émission de nouvelles actions, de dilution ou de modification des prévisions de l'entreprise.
Bel Fuse Inc. (BELFB) � Formular 144 Mitteilung
Ein Inhaber beabsichtigt, bis zu 1.200 Stammaktien über Morgan Stanley Smith Barney an der NASDAQ ab dem 31. Juli 2025 zu verkaufen. Der geplante Verkauf hat einen Wert von 152.484 $ und entspricht etwa 0,01 % der 10.548.254 ausstehenden Aktien, was auf einen unwesentlichen Anteil des Streubesitzes hinweist. Die Aktien wurden am 15. März 2025 als beschränkte Aktien vom Emittenten erworben. In den letzten drei Monaten gab es keine weiteren Verkäufe dieses Meldenden. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen über das Unternehmen vorliegen.
Diese Einreichung gewährt lediglich das Recht zum Verkauf gemäß Regel 144; sie stellt keine Verpflichtung dar, dass die Transaktion stattfindet, und beinhaltet keine Neuemissionen, Verwässerungen oder Änderungen der Unternehmensprognosen.
- None.
- None.
Insights
TL;DR: 1,200-share Form 144 filing is de-minimis; trading and valuation impact should be negligible.
The filer seeks clearance to dispose of shares worth about $152k, representing only 0.01 % of BELFB’s outstanding stock. Such a small block is unlikely to pressure liquidity or signal a broad insider exodus. No pattern of recent sales is disclosed, and the shares derive from a March 2025 restricted-stock grant, a common form of executive compensation. Because the transaction neither adds shares nor alters fundamentals, the event is considered routine. Investors typically monitor insider activity, but the scale here does not materially alter the investment thesis.
Bel Fuse Inc. (BELFB) � Avviso Modulo 144
Un detentore intende vendere fino a 1.200 azioni ordinarie tramite Morgan Stanley Smith Barney sul NASDAQ a partire dal 31 luglio 2025. La vendita proposta ha un valore di circa $152.484, corrispondente a circa lo 0,01% delle 10.548.254 azioni in circolazione, indicando una quota irrilevante del flottante. Le azioni sono state acquisite dall'emittente come azioni vincolate il 15 marzo 2025. Nessun'altra vendita da parte di questo dichiarante è avvenuta negli ultimi tre mesi. Il firmatario certifica di non possedere informazioni materiali sfavorevoli non divulgate riguardo alla società.
Questa comunicazione concede solo il diritto di vendere ai sensi della Regola 144; non rappresenta un impegno che la transazione avverrà, né comporta emissione di nuove azioni, diluizione o modifiche alle indicazioni societarie.
Bel Fuse Inc. (BELFB) � Aviso Formulario 144
Un titular pretende vender hasta 1,200 acciones comunes a través de Morgan Stanley Smith Barney en el NASDAQ a partir del 31 de julio de 2025. La venta propuesta tiene un valor de $152,484, lo que equivale aproximadamente al 0.01 % de las 10,548,254 acciones en circulación, indicando una porción insignificante del flotante. Las acciones fueron adquiridas del emisor como acciones restringidas el 15 de marzo de 2025. No se registraron otras ventas por parte de este declarante en los últimos tres meses. El firmante certifica que no posee información material adversa no divulgada sobre la compañía.
Este archivo únicamente otorga el derecho a vender bajo la Regla 144; no es un compromiso de que la transacción se realizará, ni implica emisión de nuevas acciones, dilución o cambios en la orientación corporativa.
Bel Fuse Inc. (BELFB) � Form 144 공시
보유자는 2025� 7� 31일부� Morgan Stanley Smith Barney� 통해 1,200 보통�� NASDAQ에서 매도� 예정입니�. 제안� 매도 금액은 $152,484이며, 이는 발행 주식 총수 10,548,254� � � 0.01%� 해당하여 유동 주식 � 미미� 비중임을 나타냅니�. 해당 주식은 2025� 3� 15일에 발행사로부� 제한 주식으로 취득하였습니�. � 신고인은 최근 3개월 내에 다른 매도� 하지 않았습니�. 서명자는 회사� 대� 미공� 중대� 부정적 정보가 없음� 증명합니�.
� 서류 제출은 Rule 144� 따른 매도 권리만을 부여하� 것으�, 거래가 반드� 이루어진다는 약속� 아니�, 신주 발행, 희석, 또는 회사 가이던� 변경과 관련이 없습니다.
Bel Fuse Inc. (BELFB) � Avis de formulaire 144
Un détenteur prévoit de vendre jusqu'à 1 200 actions ordinaires via Morgan Stanley Smith Barney sur le NASDAQ à partir du 31 juillet 2025. La vente proposée est évaluée à 152 484 $, ce qui représente environ 0,01 % des 10 548 254 actions en circulation, indiquant une part négligeable du flottant. Les actions ont été acquises auprès de l'émetteur en tant qu'actions restreintes le 15 mars 2025. Aucune autre vente de ce déclarant n'a eu lieu au cours des trois derniers mois. Le signataire certifie ne détenir aucune information défavorable importante non divulguée concernant la société.
Ce dépôt accorde uniquement le droit de vendre conformément à la règle 144 ; il ne constitue pas un engagement que la transaction aura lieu, ni n'implique d'émission de nouvelles actions, de dilution ou de modification des prévisions de l'entreprise.
Bel Fuse Inc. (BELFB) � Formular 144 Mitteilung
Ein Inhaber beabsichtigt, bis zu 1.200 Stammaktien über Morgan Stanley Smith Barney an der NASDAQ ab dem 31. Juli 2025 zu verkaufen. Der geplante Verkauf hat einen Wert von 152.484 $ und entspricht etwa 0,01 % der 10.548.254 ausstehenden Aktien, was auf einen unwesentlichen Anteil des Streubesitzes hinweist. Die Aktien wurden am 15. März 2025 als beschränkte Aktien vom Emittenten erworben. In den letzten drei Monaten gab es keine weiteren Verkäufe dieses Meldenden. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen über das Unternehmen vorliegen.
Diese Einreichung gewährt lediglich das Recht zum Verkauf gemäß Regel 144; sie stellt keine Verpflichtung dar, dass die Transaktion stattfindet, und beinhaltet keine Neuemissionen, Verwässerungen oder Änderungen der Unternehmensprognosen.
(To Prospectus Dated May 24, 2024)
![[MISSING IMAGE: lg_orchestrabiomedtm-4clr.jpg]](https://www.sec.gov/Archives/edgar/data/0001814114/000110465925072732/lg_orchestrabiomedtm-4clr.jpg)
Pre-Funded Warrants to Purchase Shares of Common Stock
| | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total
|
| |||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | |||
Underwriting discounts and commissions(1)
|
| | | $ | | | | | $ | | | | | $ | | | |||
Proceeds, before expenses, to us
|
| | | $ | | | | | $ | | | | | $ | | | |
| Piper Sandler | | |
TD Cowen
|
|
| | |
Page
|
| |||
ABOUT THIS PROSPECTUS SUPPLEMENT
|
| | | | S-ii | | |
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-1 | | |
THE OFFERING
|
| | | | S-6 | | |
RISK FACTORS
|
| | | | S-9 | | |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | S-13 | | |
USE OF PROCEEDS
|
| | | | S-15 | | |
DIVIDEND POLICY
|
| | | | S-16 | | |
DILUTION
|
| | | | S-17 | | |
DESCRIPTION OF PRE-FUNDED WARRANTS
|
| | | | S-19 | | |
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
|
| | | | S-21 | | |
UNDERWRITING
|
| | | | S-27 | | |
LEGAL MATTERS
|
| | | | S-37 | | |
EXPERTS
|
| | | | S-38 | | |
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | S-39 | | |
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
|
| | | | S-40 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
|
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
|
| | | | 4 | | |
|
THE COMPANY
|
| | | | 6 | | |
|
RISK FACTORS
|
| | | | 7 | | |
|
USE OF PROCEEDS
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 15 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 22 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 24 | | |
|
DESCRIPTION OF UNITS
|
| | | | 25 | | |
|
GLOBAL SECURITIES
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 30 | | |
|
LEGAL MATTERS
|
| | | | 32 | | |
|
EXPERTS
|
| | | | 33 | | |
Annual Net Sales
|
| |
Applicable Purchaser
Revenue Interest Rate |
| |||
Less than or equal to $100 million, in any field
|
| | | | 17.0% | | |
Greater than $100 million, only in the fields described above
|
| | | | 4.0% | | |
|
Public offering price per share
|
| | | | | | | | | $ | | | |
|
Net tangible book value per share as of March 31, 2025
|
| | | $ | 0.44 | | | | | | | | |
|
Increase in net tangible book value per share attributable to new investors participating in this offering
|
| | | $ | | | | | | | | | |
|
As adjusted net tangible book value per share as of March 31, 2025, after giving effect to this offering and the Private Placement
|
| | | | | | | | | $ | | | |
|
Dilution per share to new investors participating in this offering
|
| | | | | | | | | $ | | |
Underwriter
|
| |
Number
of Shares |
| |
Number
of Pre-Funded Warrants |
|
Piper Sandler & Co.
|
| |
|
| |
|
|
TD Securities (USA) LLC
|
| | | | | | |
Total
|
| | | | | | |
| | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total
Without Option Exercise |
| |
Total
With Full Option Exercise |
| ||||||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Underwriting discount and commissions
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Proceeds, before expenses, to us
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | |
150 Union Square Drive
New Hope, PA 18938
(215) 862-5797
![[MISSING IMAGE: lg_orchestrabiomedtm-4clr.jpg]](https://www.sec.gov/Archives/edgar/data/0001814114/000110465925072732/lg_orchestrabiomedtm-4clr.jpg)
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 2 | | |
|
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
|
| | | | 4 | | |
|
THE COMPANY
|
| | | | 6 | | |
|
RISK FACTORS
|
| | | | 7 | | |
|
USE OF PROCEEDS
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 15 | | |
|
DESCRIPTION OF WARRANTS
|
| | | | 22 | | |
|
DESCRIPTION OF RIGHTS
|
| | | | 24 | | |
|
DESCRIPTION OF UNITS
|
| | | | 25 | | |
|
GLOBAL SECURITIES
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 30 | | |
|
LEGAL MATTERS
|
| | | | 32 | | |
|
EXPERTS
|
| | | | 33 | | |
150 Union Square Drive
New Hope, PA 18938
(215) 862-5797
Common Stock
![[MISSING IMAGE: lg_orchestrabiomedtm-4clr.jpg]](https://www.sec.gov/Archives/edgar/data/0001814114/000110465925072732/lg_orchestrabiomedtm-4clr.jpg)
Source: